SCHEMBL9770814

SCHEMBL9770814

COC(=O)COc1ccc(CC(C)N2CCOC(c3cccc(Cl)n3)C2)cc1

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GLA P06280 2/20 0.40
ADRB2 P07550 1/20 0.40
ADRB1 P08588 1/20 0.40
ADRB3 P13945 1/20 0.40
MEN1 O00255 2/20 0.37
KMT2A Q03164 2/20 0.37
ALDH1A1 P00352 1/20 0.37
HPGD P15428 1/20 0.37
AVPR1B P47901 3/20 0.36
LMNA P02545 1/20 0.34
THRB P10828 1/20 0.34
PTGS2 P35354 1/20 0.34
HRH3 Q9Y5N1 1/20 0.34
CHRM3 P20309 1/20 0.34
ALOX5AP P20292 1/20 0.33
SMN1; SMN2 Q16637 1/20 0.33
DRD4 P21917 1/20 0.33
CYP26A1 O43174 1/20 0.33
CYP3A4 P08684 1/20 0.33
ITGA4 P13612 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9770829 0.91 ADRB2 (0.38) ADRB2ADRB1ADRB3AVPR1BLMNA
SCHEMBL9770894 0.91 AVPR1B (0.38) ADRB2ADRB1ADRB3MEN1KMT2A
SCHEMBL9770863 0.91 ADRB2 (0.39) ADRB2ADRB1ADRB3AVPR1BLMNA
SCHEMBL9770957 0.88 ALOX5AP (0.38) GLAADRB2ADRB1ADRB3ALOX5AP
SCHEMBL8879820 0.86 GLA (0.37) GLAADRB2ADRB1ADRB3MEN1
SCHEMBL9770796 0.86 ADRB2 (0.37) ADRB2ADRB1ADRB3MEN1KMT2A
SCHEMBL10505895 0.84 ADRB2 (0.49) GLAADRB2ADRB1ADRB3MEN1
SCHEMBL8880254 0.84 MEN1 (0.36) GLAADRB2ADRB1ADRB3MEN1
SCHEMBL9770835 0.84 SLC2A1 (0.35) ADRB2ADRB1ADRB3MEN1KMT2A
Hydrochloric Acid SCHEMBL10505889 0.83 ADRB2 (0.48) GLAADRB2ADRB1ADRB3MEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5026702-A Enhances physical performance in animals, effective in lowering blood sugar, reducing body fat and lowering atherogenic lipoproteins DR. KARL THOMAE, GMBH (DE) 1991-06-25 US claimed
EP-0334146-A1 Morpholines and morpholine-N-oxides, medicines containing these compounds and process for their preparation Dr. Karl Thomae GmbH (DE) 1989-09-27 EP claimed
US-5026702-A Enhances physical performance in animals, effective in lowering blood sugar, reducing body fat and lowering atherogenic lipoproteins DR. KARL THOMAE, GMBH (DE) 1991-06-25 US disclosed
EP-0334146-A1 Morpholines and morpholine-N-oxides, medicines containing these compounds and process for their preparation Dr. Karl Thomae GmbH (DE) 1989-09-27 EP disclosed